Cryptosporidium Pathogenicity and Virulence (2024)

1. Isenberg HD.1988. Pathogenicity and virulence: another view. Clin. Microbiol. Rev.1:40–53 [PMC free article] [PubMed] [Google Scholar]

2. Alonso-Monge R, Navarro-García F, Román E, Eisman B, Nombela C, Pla J.2003. Strategies for the identification of virulence determinants in human pathogenic fungi. Curr. Genet.42:301–312 [PubMed] [Google Scholar]

3. Bloch H.1950. A component of tubercle bacilli concerned with their virulence. Bull. N. Y. Acad. Med.26:506–507 [PMC free article] [PubMed] [Google Scholar]

4. Ebert D, Herre EA.1996. The evolution of parasitic diseases. Parasitol. Today12:96–101 [PubMed] [Google Scholar]

5. Garnick E.1992. Parasite virulence and parasite-host coevolution: a reappraisal. J. Parasitol.78:381–386 [PubMed] [Google Scholar]

6. Mellon R.1926. Studies in microbic heredity. VIII. The infectivity and virulence of a filtrable phase in the life history of B. fusiformis and related organisms. J. Bacteriol.12:279–298 [PMC free article] [PubMed] [Google Scholar]

7. Pike R, Mackenzie GM.1940. Virulence of Salmonella typhimurium. I. Analysis of experimental infection in mice with strains of high and low virulence. J. Bacteriol.40:171–195 [PMC free article] [PubMed] [Google Scholar]

8. Poulin R, Combes C.1999. The concept of virulence: interpretations and implications. Parasitol. Today15:474–475 [PubMed] [Google Scholar]

9. Smiley H, Pearse H.1926. Determining the virulence of positive diphtheria cultures. Am. J. Public Health (N. Y.)16:998–1002 [PMC free article] [PubMed] [Google Scholar]

10. Woolhouse ME, Webster JP, Domingo E, Charlesworth B, Levin BR.2002. Biological and biomedical implications of the co-evolution of pathogens and their hosts. Nat. Genet.32:569–577 [PubMed] [Google Scholar]

11. Casadevall A, Pirofski L.2001. Host-pathogen interactions: the attributes of virulence. J. Infect. Dis.184:337–344 [PubMed] [Google Scholar]

12. Casadevall A, Pirofski LA.1999. Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity. Infect. Immun.67:3703–3713 [PMC free article] [PubMed] [Google Scholar]

13. Okhuysen PC, Chappell CL.2002. Cryptosporidium virulence determinants—are we there yet?Int. J. Parasitol.32:517–525 [PubMed] [Google Scholar]

14. Fayer R, Orlandi P, Perdue ML.2009. Virulence factor activity relationships for hepatitis E and Cryptosporidium. J. Water Health7(Suppl 1):S55–S63doi:10.2166/wh.2009.044 [PubMed] [Google Scholar]

15. Navarro-Garcia F, Sanchez M, Nombela C, Pla J.2001. Virulence genes in the pathogenic yeast Candida albicans. FEMS Microbiol. Rev.25:245–268 [PubMed] [Google Scholar]

16. Edberg SC.2009. Does the possession of virulence factor genes mean that those genes will be active?J. Water Health7(Suppl 1):S19–S28doi:10.2166/wh.2009.066 [PubMed] [Google Scholar]

17. Karger A, Ziller M, Bettin B, Mintel B, Schares S, Geue L.2011. Determination of serotypes of Shiga toxin-producing Escherichia coli isolates by intact cell matrix-assisted laser desorption ionization-time of flight mass spectrometry. Appl. Environ. Microbiol.77:896–905 [PMC free article] [PubMed] [Google Scholar]

18. van Asten AJ, van Dijk JE.2005. Distribution of “classic” virulence factors among Salmonella spp. FEMS Immunol. Med. Microbiol.44:251–259 [PubMed] [Google Scholar]

19. Verstrepen KJ, Fink GR.2009. Genetic and epigenetic mechanisms underlying cell-surface variability in protozoa and fungi. Annu. Rev. Genet.43:1–24 [PubMed] [Google Scholar]

20. Goldston AM, Powell RR, Temesvari LA.2012. Sink or swim: lipid rafts in parasite pathogenesis. Trends Parasitol.28:417–426 [PMC free article] [PubMed] [Google Scholar]

21. Butler CE, Tyler KM.2012. Membrane traffic and synaptic cross-talk during host cell entry by Trypanosoma cruzi. Cell. Microbiol.14:1345–1353 [PMC free article] [PubMed] [Google Scholar]

22. Schmid-Hempel P.2008. Parasite immune evasion: a momentous molecular war. Trends Ecol. Evol.23:318–326 [PubMed] [Google Scholar]

23. Sibley LD.2011. Invasion and intracellular survival by protozoan parasites. Immunol. Rev.240:72–91 [PMC free article] [PubMed] [Google Scholar]

24. Landfear SM.2011. Nutrient transport and pathogenesis in selected parasitic protozoa. Eukaryot. Cell10:483–493 [PMC free article] [PubMed] [Google Scholar]

25. McKerrow JH, Caffrey C, Kelly B, Loke P, Sajid M.2006. Proteases in parasitic diseases. Annu. Rev. Pathol.1:497–536 [PubMed] [Google Scholar]

26. Ashton AW, Mukherjee S, Nagajyothi FNU, Huang H, Braunstein VL, Desruisseaux MS, Factor SM, Lopez L, Berman JW, Wittner M, Scherer PE, Capra V, Coffman TM, Serhan CN, Gotlinger K, Wu KK, Weiss LM, Tanowitz HB.2007. Thromboxane A(2) is a key regulator of pathogenesis during Trypanosoma cruzi infection. J. Exp. Med.204:929–940 [PMC free article] [PubMed] [Google Scholar]

27. Dean S, Marchetti R, Kirk K, Matthews KR.2009. A surface transporter family conveys the trypanosome differentiation signal. Nature459:213–217 [PMC free article] [PubMed] [Google Scholar]

28. McClelland E, Bernhardt P, Casadevall A.2006. Estimating the relative contributions of virulence factors for pathogenic microbes. Infect. Immun.74:1500–1504 [PMC free article] [PubMed] [Google Scholar]

29. Tyzzer EE.1907. A sporozoan found in the peptic glands of the common mouse. Proc. Soc. Exp. Biol. Med.5:12–13 [Google Scholar]

30. Tyzzer EE.1912. Cryptosporidium parvum (sp. nov.), a coccidium found in the small intestine of the common mouse. Arch. Protistenkd.26:394–412 [Google Scholar]

31. Slavin D.1955. Cryptosporidium meleagridis (sp. nov.). J. Comp. Pathol.65:262–266 [PubMed] [Google Scholar]

32. Panciera RJ, Thomassen RW, Gardner FM.1971. Cryptosporidial infection in a calf. Vet. Pathol.8:479–484 [Google Scholar]

33. Current W, Garcia LS.1991. Cryptosporidiosis. Clin. Microbiol. Rev.4:325–358 [PMC free article] [PubMed] [Google Scholar]

34. De Graaf D, Vanopdenbosch E, Ortega-Mora LM, Abbassi H, Peeters JE.1999. A review of the importance of cryptosporidiosis in farm animals. Int. J. Parasitol.29:1269–1287 [PMC free article] [PubMed] [Google Scholar]

35. Holland R.1990. Some infectious causes of diarrhea in young farm animals. Clin. Microbiol. Rev.3:345–375 [PMC free article] [PubMed] [Google Scholar]

36. Meuten D, Van Kruiningen HJ, Lein DH.1974. Cryptosporidiosis in a calf. J. Am. Vet. Med. Assoc.165:914–917 [PubMed] [Google Scholar]

37. Moore AC, Herwaldt BL, Craun GF, Calderon RL, Highsmith AK, Juranek DD.1993. Surveillance for waterborne disease outbreaks—United States, 1991-1992. MMWR CDC Surveill. Summ.42:1–22 [PubMed] [Google Scholar]

38. O'Handley R, Olson ME.2006. Giardiasis and cryptosporidiosis in ruminants. Vet. Clin. North Am. Food Anim. Pract.22:623–643 [PubMed] [Google Scholar]

39. Tzipori S, Campbell I, Sherwood D, Snodgrass DR, Whitelaw A.1980. An outbreak of calf diarrhoea attributed to cryptosporidial infection. Vet. Rec.107:579–580 [PubMed] [Google Scholar]

40. Blagburn B, Lindsay DS, Giambrone JJ, Sundermann CA, ho*rr FJ.1987. Experimental cryptosporidiosis in broiler chickens. Poult. Sci.66:442–449 [PubMed] [Google Scholar]

41. Current W, Snyder DB.1988. Development of and serologic evaluation of acquired immunity to Cryptosporidium baileyi by broiler chickens. Poult. Sci.67:720–729 [PubMed] [Google Scholar]

42. Goodwin M.1989. Cryptosporidiosis in birds—a review. Avian Pathol.18:365–384 [PubMed] [Google Scholar]

43. O'Donoghue P.1995. Cryptosporidium and cryptosporidiosis in man and animals. Int. J. Parasitol.25:139–195 [PubMed] [Google Scholar]

44. Meisel J, Perera DR, Meligro C, Rubin CE.1976. Overwhelming watery diarrhea associated with a cryptosporidium in an immunosuppressed patient. Gastroenterology70:1156–1160 [PubMed] [Google Scholar]

45. Nime F, Burek JD, Page DL, Holscher MA, Yardley JH.1976. Acute enterocolitis in a human being infected with the protozoan Cryptosporidium. Gastroenterology70:592–598 [PubMed] [Google Scholar]

46. Crawford F, Vermund SH.1988. Human cryptosporidiosis. Crit. Rev. Microbiol.16:113–159 [PubMed] [Google Scholar]

47. Current W, Reese NC, Ernst JV, Bailey WS, Heyman MB, Weinstein WM.1983. Human cryptosporidiosis in immunocompetent and immunodeficient persons. Studies of an outbreak and experimental transmission. N. Engl. J. Med.308:1252–1257 [PubMed] [Google Scholar]

48. Fayer R, Ungar BL.1986. Cryptosporidium spp. and cryptosporidiosis. Microbiol. Rev.50:458–483 [PMC free article] [PubMed] [Google Scholar]

49. Forgacs P, Tarshis A, Ma P, Federman M, Mele L, Silverman ML, Shea JA.1983. Intestinal and bronchial cryptosporidiosis in an immunodeficient hom*osexual man. Ann. Intern. Med.99:793–794 [PubMed] [Google Scholar]

50. Ma P, Soave R.1983. Three-step stool examination for cryptosporidiosis in 10 hom*osexual men with protracted watery diarrhea. J. Infect. Dis.147:824–828 [PubMed] [Google Scholar]

51. Soave R, Danner RL, Honig CL, Ma P, Hart CC, Nash T, Roberts RB.1984. Cryptosporidiosis in hom*osexual men. Ann. Intern. Med.100:504–511 [PubMed] [Google Scholar]

52. Jokipii L, Pohjola S, Jokipii AM.1983. Cryptosporidium: a frequent finding in patients with gastrointestinal symptoms. Lancetii:358–361 [PubMed] [Google Scholar]

53. Tzipori S, Smith M, Birch C, Barnes G, Bishop R.1983. Cryptosporidiosis in hospital patients with gastroenteritis. Am. J. Trop. Med. Hyg.32:931–934 [PubMed] [Google Scholar]

54. Karanis P, Kourenti C, Smith H.2007. Waterborne transmission of protozoan parasites: a worldwide review of outbreaks and lessons learnt. J. Water Health5:1–38 [PubMed] [Google Scholar]

55. Meinhardt P, Casemore DP, Miller KB.1996. Epidemiologic aspects of human cryptosporidiosis and the role of waterborne transmission. Epidemiol. Rev.18:118–136 [PubMed] [Google Scholar]

56. Blackburn BG, Craun GF, Yoder JS, Hill V, Calderon RL, Chen N, Lee SH, Levy DA, Beach MJ.2004. Surveillance for waterborne-disease outbreaks associated with drinking water—United States, 2001-2002. MMWR Surveill. Summ.53:23–45 [PubMed] [Google Scholar]

57. Chen X, Keithly JS, Paya CV, LaRusso NF.2002. Cryptosporidiosis. N. Engl. J. Med.346:1723–1731 [PubMed] [Google Scholar]

58. Juranek D.1995. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin. Infect. Dis.22:S57–S61doi:10.1093/clinids/21.Supplement_1.S57 [PubMed] [Google Scholar]

59. Manabe YC, Clark DP, Moore RD, Lumadue JA, Dahlman HR, Belitsos PC, Chaisson RE, Sears CL.1998. Cryptosporidiosis in patients with AIDS: correlates of disease and survival. Clin. Infect. Dis.27:536–542 [PubMed] [Google Scholar]

60. Hunter P, Nichols G.2002. Epidemiology and clinical features of Cryptosporidium infection in immunocompromised patients. Clin. Microbiol. Rev.15:145–154 [PMC free article] [PubMed] [Google Scholar]

61. Chalmers RM, Davies AP.2010. Clinical cryptosporidiosis. Exp. Parasitol.124:138–146 [PubMed] [Google Scholar]

62. Cacciò S.2005. Molecular epidemiology of human cryptosporidiosis. Parassitologia47:185–192 [PubMed] [Google Scholar]

63. Bouzid M, Tyler KM, Christen R, Chalmers RM, Elwin K, Hunter PR.2010. Multi-locus analysis of human infective Cryptosporidium species and subtypes using ten novel genetic loci. BMC Microbiol.10:213doi:10.1186/1471-2180-10-213 [PMC free article] [PubMed] [Google Scholar]

64. Chalmers RM, Smith R, Elwin K, Clifton-Hadley FA, Giles M.2011. Epidemiology of anthroponotic and zoonotic human cryptosporidiosis in England and Wales, 2004-2006. Epidemiol. Infect.139:700–712 [PubMed] [Google Scholar]

65. Cama VA, Ross JM, Crawford S, Kawai V, Chavez-Valdez R, Vargas D, Vivar A, Ticona E, Navincopa M, Williamson J, Ortega Y, Gilman RH, Bern C, Xiao L.2007. Differences in clinical manifestations among Cryptosporidium species and subtypes in HIV-infected persons. J. Infect. Dis.196:684–691 [PubMed] [Google Scholar]

66. Cama VA, Bern C, Roberts J, Cabrera L, Sterling CR, Ortega Y, Gilman RH, Xiao L.2008. Cryptosporidium species and subtypes and clinical manifestations in children, Peru. Emerg. Infect. Dis.14:1567–1574 [PMC free article] [PubMed] [Google Scholar]

67. Hunter P, Hughes S, Woodhouse S, Raj N, Syed Q, Chalmers RM, Verlander NQ, Goodacre J.2004. Health sequelae of human cryptosporidiosis in immunocompetent patients. Clin. Infect. Dis.39:504–510 [PubMed] [Google Scholar]

68. Casemore D, Sands RL, Curry A.1985. Cryptosporidium species a “new” human pathogen. J. Clin. Pathol.38:1321–1336 [PMC free article] [PubMed] [Google Scholar]

69. Hunter P, Thompson RC.2005. The zoonotic transmission of Giardia and Cryptosporidium. Int. J. Parasitol.35:1181–1190 [PubMed] [Google Scholar]

70. Xiao L, Feng Y.2008. Zoonotic cryptosporidiosis. FEMS Immunol. Med. Microbiol.52:309–323 [PubMed] [Google Scholar]

71. Glaberman S, Moore JE, Lowery CJ, Chalmers RM, Sulaiman I, Elwin K, Rooney PJ, Millar BC, Dooley JS, Lal AA, Xiao L.2002. Three drinking-water-associated cryptosporidiosis outbreaks, Northern Ireland. Emerg. Infect. Dis.8:631–633 [PMC free article] [PubMed] [Google Scholar]

72. Guerrant R.1997. Cryptosporidiosis: an emerging, highly infectious threat. Emerg. Infect. Dis.3:51–57 [PMC free article] [PubMed] [Google Scholar]

73. Hayes EB, Matte TD, O'Brien TR, McKinley TW, Logsdon GS, Rose JB, Ungar BLP, Word DM, Wilson MA, Long EG, Hurwitz ES, Juranek DD.1989. Large community outbreak of cryptosporidiosis due to contamination of a filtered public water supply. N. Engl. J. Med.320:1372–1376 [PubMed] [Google Scholar]

74. Jiang J, Alderisio KA, Xiao L.2005. Distribution of Cryptosporidium genotypes in storm event water samples from three watersheds in New York. Appl. Environ. Microbiol.71:4446–4454 [PMC free article] [PubMed] [Google Scholar]

75. Xiao L, Alderisio K, Limor J, Royer M, Lal AA.2000. Identification of species and sources of Cryptosporidium oocysts in storm waters with a small-subunit rRNA-based diagnostic and genotyping tool. Appl. Environ. Microbiol.66:5492–5498 [PMC free article] [PubMed] [Google Scholar]

76. Egger M, Mäusezahl D, Odermatt P, Marti HP, Tanner M.1990. Symptoms and transmission of intestinal cryptosporidiosis. Arch. Dis. Child.65:445–447 [PMC free article] [PubMed] [Google Scholar]

77. Harari M, West B, Dwyer B.1986. Cryptosporidium as cause of laryngotracheitis in an infant. Lanceti:1207doi:10.1016/S0140-6736(86)91181-5 [PubMed] [Google Scholar]

78. Ma P, Villanueva TG, Kaufman D, Gillooley JF.1984. Respiratory cryptosporidiosis in the acquired immune deficiency syndrome. Use of modified cold kinyoun and hemacolor stains for rapid diagnoses. JAMA252:1298–1301 [PubMed] [Google Scholar]

79. Tzipori S, Ward H.2002. Cryptosporidiosis: biology, pathogenesis and disease. Microbes Infect.4:1047–1058 [PubMed] [Google Scholar]

80. Goldstein ST, Juranek DD, Ravenholt O, Hightower AW, Martin DG, Mesnik JL, Griffiths SD, Bryant AJ, Reich RR, Herwaldt BL.1996. Cryptosporidiosis: an outbreak associated with drinking water despite state-of-the-art water treatment. Ann. Intern. Med.124:459–468 [PubMed] [Google Scholar]

81. Kramer MH, Sorhage FE, Goldstein ST, Dalley E, Wahlquist SP, Herwaldt BL.1998. First reported outbreak in the United States of cryptosporidiosis associated with a recreational lake. Clin. Infect. Dis.26:27–33 [PubMed] [Google Scholar]

82. MacKenzie WR, Schell WL, Blair KA, Addiss DG, Peterson DE, Hoxie NJ, Kazmierczak JJ, Davis JP.1995. Massive outbreak of waterborne cryptosporidium infection in Milwaukee, Wisconsin—recurrence of illness and risk of secondary transmission. Clin. Infect. Dis.21:57–62 [PubMed] [Google Scholar]

83. McAnulty JM, Fleming DW, Gonzalez AH.1994. A community-wide outbreak of cryptosporidiosis associated with swimming at a wave pool. JAMA272:1597–1600 [PubMed] [Google Scholar]

84. Yoder JS, Beach MJ.2010. Cryptosporidium surveillance and risk factors in the United States. Exp. Parasitol.124:31–39 [PubMed] [Google Scholar]

85. Robertson B, Sinclair MI, Forbes AB, Veitch M, Kirk M, Cunliffe D, Willis J, Fairley CK.2002. Case-control studies of sporadic cryptosporidiosis in Melbourne and Adelaide, Australia. Epidemiol. Infect.128:419–431 [PMC free article] [PubMed] [Google Scholar]

86. Roy S, DeLong SM, Stenzel SA, Shiferaw B, Roberts JM, Khalakdina A, Marcus R, Segler SD, Shah DD, Thomas S, Vugia DJ, Zansky SM, Dietz V, Beach MJ, Emerging Infections Program FoodNet Working Group2004. Risk factors for sporadic cryptosporidiosis among immunocompetent persons in the United States from 1999 to 2001. J. Clin. Microbiol.42:2944–2951 [PMC free article] [PubMed] [Google Scholar]

87. Goh S, Reacher M, Casemore DP, Verlander NQ, Chalmers R, Knowles M, Williams J, Osborn K, Richards S.2004. Sporadic cryptosporidiosis, North Cumbria, England, 1996-2000. Emerg. Infect. Dis.10:1007–1015 [PMC free article] [PubMed] [Google Scholar]

88. Pintar KD, Pollari F, Waltner-Toews D, Charron DF, McEwen SA, Fazil A, Nesbitt A.2009. A modified case-control study of cryptosporidiosis (using non-Cryptosporidium-infected enteric cases as controls) in a community setting. Epidemiol. Infect.137:1789–1799 [PubMed] [Google Scholar]

89. Valderrama AL, Hlavsa MC, Cronquist A, Cosgrove S, Johnston SP, Roberts JM, Stock ML, Xiao L, Xavier K, Beach MJ.2009. Multiple risk factors associated with a large statewide increase in cryptosporidiosis. Epidemiol. Infect.137:1781–1788 [PubMed] [Google Scholar]

90. Frost FJ, Roberts M, Kunde TR, Craun G, Tollestrup K, Harter L, Muller T.2005. How clean must our drinking water be: the importance of protective immunity. J. Infect. Dis.191:809–814 [PubMed] [Google Scholar]

91. Colford JM, Jr, Saha SR, Wade TJ, Wright CC, Vu M, Charles S, Jensen P, Hubbard A, Levy DA, Eisenberg JN.2005. A pilot randomized, controlled trial of an in-home drinking water intervention among HIV+ persons. J. Water Health3:173–184 [PubMed] [Google Scholar]

92. Dwivedi KK, Prasad G, Saini S, Mahajan S, Lal S, Baveja UK.2007. Enteric opportunistic parasites among HIV infected individuals: associated risk factors and immune status. Jpn. J. Infect. Dis.60:76–81 [PubMed] [Google Scholar]

93. Hellard M, Hocking J, Willis J, Dore G, Fairley C.2003. Risk factors leading to Cryptosporidium infection in men who have sex with men. Sex. Transm. Infect.79:412–414 [PMC free article] [PubMed] [Google Scholar]

94. Becher KA, Robertson ID, Fraser DM, Palmer DG, Thompson RC.2004. Molecular epidemiology of Giardia and Cryptosporidium infections in dairy calves originating from three sources in Western Australia. Vet. Parasitol.123:1–9 [PubMed] [Google Scholar]

95. Horman A, Korpela H, Sutinen J, Wedel H, Hanninen ML.2004. Meta-analysis in assessment of the prevalence and annual incidence of Giardia spp. and Cryptosporidium spp. infections in humans in the Nordic countries. Int. J. Parasitol.34:1337–1346 [PubMed] [Google Scholar]

96. Nimri L, Batchoun R.1994. Prevalence of Cryptosporidium species in elementary school children. J. Clin. Microbiol.32:1040–1042 [PMC free article] [PubMed] [Google Scholar]

97. Okafor JI, Okunji PO.1996. Prevalence of Cryptosporidium oocysts in faecal samples of some school children in Enugu State, Nigeria. J. Commun. Dis.28:49–55 [PubMed] [Google Scholar]

98. Wallis PM, Erlandsen SL, Isaac-Renton JL, Olson ME, Robertson WJ, van Keulen H.1996. Prevalence of Giardia cysts and Cryptosporidium oocysts and characterization of Giardia spp. isolated from drinking water in Canada. Appl. Environ. Microbiol.62:2789–2797 [PMC free article] [PubMed] [Google Scholar]

99. Blanco MA, Iborra A, Vargas A, Nsie E, Mba L, Fuentes I.2009. Molecular characterization of Cryptosporidium isolates from humans in Equatorial Guinea. Trans. R. Soc. Trop. Med. Hyg.103:1282–1284 [PubMed] [Google Scholar]

100. Leoni F, Amar C, Nichols G, Pedraza-Díaz S, McLauchlin J.2006. Genetic analysis of Cryptosporidium from 2414 humans with diarrhoea in England between 1985 and 2000. J. Med. Microbiol.55:703–707 [PubMed] [Google Scholar]

101. Mueller-Doblies D, Giles M, Elwin K, Smith RP, Clifton-Hadley FA, Chalmers RM.2008. Distribution of Cryptosporidium species in sheep in the UK. Vet. Parasitol.154:214–219 [PubMed] [Google Scholar]

102. Brook EJ, Anthony Hart C, French NP, Christley RM.2009. Molecular epidemiology of Cryptosporidium subtypes in cattle in England. Vet. J.179:378–382 [PubMed] [Google Scholar]

103. Chalmers R, Hadfield SJ, Jackson CJ, Elwin K, Xiao L, Hunter P.2008. Geographic linkage and variation in Cryptosporidium hominis. Emerg. Infect. Dis.14:496–498 [PMC free article] [PubMed] [Google Scholar]

104. Geurden T, Levecke B, Caccio SM, Visser A, De Groote G, Casaert S, Vercruysse J, Claerebout E.2009. Multilocus genotyping of Cryptosporidium and Giardia in non-outbreak related cases of diarrhoea in human patients in Belgium. Parasitology136:1161–1168 [PubMed] [Google Scholar]

105. Hunter P, Hadfield SJ, Wilkinson D, Lake IR, Harrison FC, Chalmers RM.2007. Subtypes of Cryptosporidium parvum in humans and disease risk. Emerg. Infect. Dis.13:82–88 [PMC free article] [PubMed] [Google Scholar]

106. Xiao L, Hlavsa MC, Yoder J, Ewers C, Dearen T, Yang W, Nett R, Harris S, Brend SM, Harris M, Onischuk L, Valderrama AL, Cosgrove S, Xavier K, Hall N, Romero S, Young S, Johnston SP, Arrowood M, Roy S, Beach MJ.2009. Subtype analysis of Cryptosporidium specimens from sporadic cases in Colorado, Idaho, New Mexico, and Iowa in 2007: widespread occurrence of one Cryptosporidium hominis subtype and case history of an infection with the Cryptosporidium horse genotype. J. Clin. Microbiol.47:3017–3020 [PMC free article] [PubMed] [Google Scholar]

107. Zintl A, Proctor AF, Read C, Dewaal T, Shanaghy N, Fanning S, Mulcahy G.2009. The prevalence of Cryptosporidium species and subtypes in human faecal samples in Ireland. Epidemiol. Infect.137:270–277 [PubMed] [Google Scholar]

108. Alves M, Xiao L, Antunes F, Matos O.2006. Distribution of Cryptosporidium subtypes in humans and domestic and wild ruminants in Portugal. Parasitol. Res.99:287–292 [PubMed] [Google Scholar]

109. Leav B, Mackay MR, Anyanwu A, O'Connor RM, Cevallos AM, Kindra G, Rollins NC, Bennish ML, Nelson RG, Ward HD.2002. Analysis of sequence diversity at the highly polymorphic Cpgp40/15 locus among Cryptosporidium isolates from human immunodeficiency virus-infected children in South Africa. Infect. Immun.70:3881–3890 [PMC free article] [PubMed] [Google Scholar]

110. Fayer R, Morgan U, Upton SJ.2000. Epidemiology of Cryptosporidium: transmission, detection and identification. Int. J. Parasitol.30:1305–1322 [PubMed] [Google Scholar]

111. Ramirez N, Ward LA, Sreevatsan S.2004. A review of the biology and epidemiology of cryptosporidiosis in humans and animals. Microbes Infect.6:773–785 [PubMed] [Google Scholar]

112. Tzipori S, Widmer G.2008. A hundred-year retrospective on cryptosporidiosis. Trends Parasitol.24:184–189 [PMC free article] [PubMed] [Google Scholar]

113. Xiao L, Fayer R.2008. Molecular characterisation of species and genotypes of Cryptosporidium and Giardia and assessment of zoonotic transmission. Int. J. Parasitol.38:1239–1255 [PubMed] [Google Scholar]

114. Xiao L.2010. Molecular epidemiology of cryptosporidiosis: an update. Exp. Parasitol.124:80–89 [PubMed] [Google Scholar]

115. Jex AR, Smith HV, Monis PT, Campbell BE, Gasser RB.2008. Cryptosporidium—biotechnological advances in the detection, diagnosis and analysis of genetic variation. Biotechnol. Adv.26:304–317 [PubMed] [Google Scholar]

116. Chalmers RM, Campbell B, Crouch N, Davies AP.2010. Clinical laboratory practices for detection and reporting of Cryptosporidium in community cases of diarrhoea in the United Kingdom, 2008. Euro Surveill.15(48):pii=19731. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19731 [PubMed] [Google Scholar]

117. Bouzid M, Steverding D, Tyler KM.2008. Detection and surveillance of waterborne protozoan parasites. Curr. Opin. Biotechnol.19:302–306 [PubMed] [Google Scholar]

118. Bruijnesteijn van Coppenraet LES, Wallinga JA, Ruijs GJHM, Bruins MJ, Verweij JJ.2009. Parasitological diagnosis combining an internally controlled real-time PCR assay for the detection of four protozoa in stool samples with a testing algorithm for microscopy. Clin. Microbiol. Infect.15:869–874 [PubMed] [Google Scholar]

119. Laxer MA, Timblin BK, Patel RJ.1991. DNA sequences for the specific detection of Cryptosporidium parvum by the polymerase chain reaction. Am. J. Trop. Med. Hyg.45:688–694 [PubMed] [Google Scholar]

120. Amar CFL, East CL, Gray J, Iturriza-Gomara M, Maclure EA, McLauchlin J.2007. Detection by PCR of eight groups of enteric pathogens in 4,627 faecal samples: re-examination of the English case-control Infectious Intestinal Disease Study (1993-1996). Eur. J. Clin. Microbiol. Infect. Dis.26:311–323 [PubMed] [Google Scholar]

121. Chalmers RM, Campbell BM, Crouch N, Charlett A, Davies AP.2011. Comparison of diagnostic sensitivity and specificity of seven Cryptosporidium assays used in the UK. J. Med. Microbiol.60:1598–1604 [PubMed] [Google Scholar]

122. Davies AP, Chalmers RM.2009. Cryptosporidiosis. BMJ339:b4168doi:10.1136/bmj.b4168 [PubMed] [Google Scholar]

123. Widmer G, Sullivan S.2012. Genomics and population biology of Cryptosporidium species. Parasite Immunol.34:61–71 [PMC free article] [PubMed] [Google Scholar]

124. Robinson G, Chalmers RM.2012. Assessment of polymorphic genetic markers for multi-locus typing of Cryptosporidium parvum and Cryptosporidium hominis. Exp. Parasitol.132:200–215 [PubMed] [Google Scholar]

125. Barta JR, Thompson RC.2006. What is Cryptosporidium? Reappraising its biology and phylogenetic affinities. Trends Parasitol.22:463–468 [PubMed] [Google Scholar]

126. Thompson RC, Olson ME, Zhu G, Enomoto S, Abrahamsen MS, Hijjawi NS.2005. Cryptosporidium and cryptosporidiosis. Adv. Parasitol.59:77–158 [PubMed] [Google Scholar]

127. Rosales MJ, Cordon GP, Moreno MS, Sanchez CM.2005. Extracellular like-gregarine stages of Cryptosporidium parvum. Acta Trop.95:74–78 [PubMed] [Google Scholar]

128. Fayer R, Leek RG.1984. The effects of reducing conditions, medium, pH, temperature, and time on in vitro excystation of Cryptosporidium. J. Protozool.31:567–569 [PubMed] [Google Scholar]

129. Reduker D, Speer CA.1985. Factors influencing excystation in Cryptosporidium oocysts from cattle. J. Parasitol.71:112–115 [PubMed] [Google Scholar]

130. Robertson L, Campbell AT, Smith HV.1993. In vitro excystation of Cryptosporidium parvum. Parasitology106:13–19 [PubMed] [Google Scholar]

131. Wetzel DM, Schmidt J, Kuhlenschmidt MS, Dubey JP, Sibley LD.2005. Gliding motility leads to active cellular invasion by Cryptosporidium parvum sporozoites. Infect. Immun.73:5379–5387 [PMC free article] [PubMed] [Google Scholar]

132. Chen XM, O'Hara SP, Huang BQ, Nelson JB, Lin JJ, Zhu G, Ward HD, LaRusso NF.2004. Apical organelle discharge by Cryptosporidium parvum is temperature, cytoskeleton, and intracellular calcium dependent and required for host cell invasion. Infect. Immun.72:6806–6816 [PMC free article] [PubMed] [Google Scholar]

133. Wanyiri J, Ward H.2006. Molecular basis of Cryptosporidium-host cell interactions: recent advances and future prospects. Future Microbiol.1:201–208 [PubMed] [Google Scholar]

134. Tetley L, Brown SM, McDonald V, Coombs GH.1998. Ultrastructural analysis of the sporozoite of Cryptosporidium parvum. Microbiology144(Part 12):3249–3255 [PubMed] [Google Scholar]

135. Boulter-Bitzer J, Lee H, Trevors JT.2007. Molecular targets for detection and immunotherapy in Cryptosporidium parvum. Biotechnol. Adv.25:13–44 [PubMed] [Google Scholar]

136. Bonnin A, Dubremetz JF, Camerlynck P.1993. A new antigen of Cryptosporidium parvum micronemes possessing epitopes cross-reactive with macrogamete granules. Parasitol. Res.79:8–14 [PubMed] [Google Scholar]

137. Petersen C, Gut J, Doyle PS, Crabb JH, Nelson RG, Leech JH.1992. Characterization of a >900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin. Infect. Immun.60:5132–5138 [PMC free article] [PubMed] [Google Scholar]

138. Tomley FM, Soldati DS.2001. Mix and match modules: structure and function of microneme proteins in apicomplexan parasites. Trends Parasitol.17:81–88 [PubMed] [Google Scholar]

139. Göbel E, Brändler U.1982. Ultrastructure of microgametogenesis, microgametes and gametogony of Cryptosporidium sp. in the small intestine of mice. Protistologica18:331–344 [Google Scholar]

140. Smith H, Rose JB.1998. Waterborne cryptosporidiosis: current status. Parasitol. Today14:14–22 [PubMed] [Google Scholar]

141. Current W, Reese NC.1986. A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice. J. Protozool.33:98–108 [PubMed] [Google Scholar]

142. Siński E, Behnke JM.2004. Apicomplexan parasites: environmental contamination and transmission. Pol. J. Microbiol.53:67–73 [PubMed] [Google Scholar]

143. DuPont H, Chappell CL, Sterling CR, Okhuysen PC, Rose JB, Jakubowski W.1995. The infectivity of Cryptosporidium parvum in healthy volunteers. N. Engl. J. Med.332:855–859 [PubMed] [Google Scholar]

144. Jokipii L, Jokipii AM.1986. Timing of symptoms and oocyst excretion in human cryptosporidiosis. N. Engl. J. Med.315:1643–1647 [PubMed] [Google Scholar]

145. Okhuysen PC, Chappell CL, Crabb JH, Sterling CR, DuPont HL.1999. Virulence of three distinct Cryptosporidium parvum isolates for healthy adults. J. Infect. Dis.180:1275–1281 [PubMed] [Google Scholar]

146. Blunt D, Khramtsov NV, Upton SJ, Montelone BA.1997. Molecular karyotype analysis of Cryptosporidium parvum: evidence for eight chromosomes and a low-molecular-size molecule. Clin. Diagn. Lab. Immunol.4:11–13 [PMC free article] [PubMed] [Google Scholar]

147. Hays M, Mosier DA, Oberst RD.1995. Enhanced karyotype resolution of Cryptosporidium parvum by contour-clamped hom*ogeneous electric fields. Vet. Parasitol.58:273–280 [PubMed] [Google Scholar]

148. Khramtsov N, Woods KM, Nesterenko MV, Dykstra CC, Upton SJ.1997. Virus-like, double-stranded RNAs in the parasitic protozoan Cryptosporidium parvum. Mol. Microbiol.26:289–300 [PubMed] [Google Scholar]

149. Clark D.1999. New insights into human cryptosporidiosis. Clin. Microbiol. Rev.12:554–563 [PMC free article] [PubMed] [Google Scholar]

150. Le Blancq S, Khramtsov NV, Zamani F, Upton SJ, Wu TW.1997. Ribosomal RNA gene organization in Cryptosporidium parvum. Mol. Biochem. Parasitol.90:463–478 [PubMed] [Google Scholar]

151. LaGier M, Tachezy J, Stejskal F, Kutisova K, Keithly JS.2003. Mitochondrial-type iron-sulfur cluster biosynthesis genes (IscS and IscU) in the apicomplexan Cryptosporidium parvum. Microbiology149:3519–3530 [PubMed] [Google Scholar]

152. Zhu G, Marchewka MJ, Keithly JS.2000. Cryptosporidium parvum appears to lack a plastid genome. Microbiology146:315–321 [PubMed] [Google Scholar]

153. Abrahamsen M, Templeton TJ, Enomoto S, Abrahante JE, Zhu G, Lancto CA, Deng M, Liu C, Widmer G, Tzipori S, Buck GA, Xu P, Bankier AT, Dear PH, Konfortov BA, Spriggs HF, Iyer L, Anantharaman V, Aravind L, Kapur V.2004. Complete genome sequence of the apicomplexan, Cryptosporidium parvum. Science304:441–445 [PubMed] [Google Scholar]

154. Xu P, Widmer G, Wang Y, Ozaki LS, Alves JM, Serrano MG, Puiu D, Manque P, Akiyoshi D, Mackey AJ, Pearson WR, Dear PH, Bankier AT, Peterson DL, Abrahamsen MS, Kapur V, Tzipori S, Buck GA.2004. The genome of Cryptosporidium hominis. Nature431:1107–1112 [PubMed] [Google Scholar]

155. Widmer G, Carlton JM, Silva JC, London E.2007. The Cryptosporidium muris genome project: a progress report, abstr 114. Abstr. 2nd Int. Giardia Cryptosporidium Conf., Morelia, Michoacan, Mexico, 13 to 18 May 2007 [Google Scholar]

156. Rider SD, Jr, Zhu G.2010. Cryptosporidium: genomic and biochemical features. Exp. Parasitol.124:2–9 [PMC free article] [PubMed] [Google Scholar]

157. Pain A, Crossman L, Parkhill J.2005. Comparative apicomplexan genomics. Nat. Rev. Microbiol.3:454–455 [PubMed] [Google Scholar]

158. Keithly J, Langreth SG, Buttle KF, Mannella CA.2005. Electron tomographic and ultrastructural analysis of the Cryptosporidium parvum relict mitochondrion, its associated membranes, and organelles. J. Eukaryot. Microbiol.52:132–140 [PubMed] [Google Scholar]

159. Puiu D, Enomoto S, Buck GA, Abrahamsen MS, Kissinger JC.2004. CryptoDB: the Cryptosporidium genome resource. Nucleic Acids Res.32:D329–D331doi:10.1093/nar/gkh050 [PMC free article] [PubMed] [Google Scholar]

160. Striepen B, Kissinger JC.2004. Genomics meets transgenics in search of the elusive Cryptosporidium drug target. Trends Parasitol.20:355–358 [PubMed] [Google Scholar]

161. Templeton T, Iyer LM, Anantharaman V, Enomoto S, Abrahante JE, Subramanian GM, Hoffman SL, Abrahamsen MS, Aravind L.2004. Comparative analysis of apicomplexa and genomic diversity in eukaryotes. Genome Res.14:1686–1695 [PMC free article] [PubMed] [Google Scholar]

162. Gordon JL, Sibley LD.2005. Comparative genome analysis reveals a conserved family of actin-like proteins in apicomplexan parasites. BMC Genomics6:179doi:10.1186/1471-2164-6-179 [PMC free article] [PubMed] [Google Scholar]

163. Nagamune K, Sibley LD.2006. Comparative genomic and phylogenetic analyses of calcium ATPases and calcium-regulated proteins in the apicomplexa. Mol. Biol. Evol.23:1613–1627 [PubMed] [Google Scholar]

164. Kuo C, Wares JP, Kissinger JC.2008. The apicomplexan whole-genome phylogeny: an analysis of incongruence among gene trees. Mol. Biol. Evol.25:2689–2698 [PMC free article] [PubMed] [Google Scholar]

165. Bouzid M, Hunter PR, McDonald V, Elwin K, Chalmers RM, Tyler KM.2012. A new heterogeneous family of telomerically encoded Cryptosporidium proteins. Evol. Appl.doi:10.1111/j.1752-4571.2012.00277.x [PMC free article] [PubMed] [Google Scholar]

166. Widmer G, Lee Y, Hunt P, Martinelli A, Tolkoff M, Bodi K.2012. Comparative genome analysis of two Cryptosporidium parvum isolates with different host range. Infect. Genet. Evol.12:1213–1221 [PMC free article] [PubMed] [Google Scholar]

167. Snelling WJ, Lin Q, Moore JE, Millar BC, Tosini F, Pozio E, Dooley JS, Lowery CJ.2007. Proteomics analysis and protein expression during sporozoite excystation of Cryptosporidium parvum (Coccidia, Apicomplexa). Mol. Cell. Proteomics6:346–355 [PubMed] [Google Scholar]

168. Artz JD, Wernimont AK, Allali-Hassani A, Zhao Y, Amani M, Lin YH, Senisterra G, Wasney GA, Fedorov O, King O, Roos A, Lunin VV, Qiu W, Finerty P, Jr, Hutchinson A, Chau I, von Delft F, Mackenzie F, Lew J, Kozieradzki I, Vedadi M, Schapira M, Zhang C, Shokat K, Heightman T, Hui R.2011. The Cryptosporidium parvum kinome. BMC Genomics12:478doi:10.1186/1471-2164-12-478 [PMC free article] [PubMed] [Google Scholar]

169. Okhuysen PC, Chappell CL, Kettner C, Sterling CR.1996. Cryptosporidium parvum metalloaminopeptidase inhibitors prevent in vitro excystation. Antimicrob. Agents Chemother.40:2781–2784 [PMC free article] [PubMed] [Google Scholar]

170. Riggs MW, Stone AL, Yount PA, Langer RC, Arrowood MJ, Bentley DL.1997. Protective monoclonal antibody defines a circ*msporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites. J. Immunol.158:1787–1795 [PubMed] [Google Scholar]

171. Strong W, Gut J, Nelson RG.2000. Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products. Infect. Immun.68:4117–4134 [PMC free article] [PubMed] [Google Scholar]

172. Cevallos A, Zhang X, Waldor MK, Jaison S, Zhou X, Tzipori S, Neutra MR, Ward HD.2000. Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect. Immun.68:4108–4116 [PMC free article] [PubMed] [Google Scholar]

173. Cevallos AM, Bhat N, Verdon R, Hamer DH, Stein B, Tzipori S, Pereira ME, Keusch GT, Ward HD.2000. Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody. Infect. Immun.68:5167–5175 [PMC free article] [PubMed] [Google Scholar]

174. Perryman LE, Jasmer DP, Riggs MW, Bohnet SG, McGuire TC, Arrowood MJ.1996. A cloned gene of Cryptosporidium parvum encodes neutralization-sensitive epitopes. Mol. Biochem. Parasitol.80:137–147 [PubMed] [Google Scholar]

175. Arrowood MJ, Sterling CR, Healey MC.1991. Immunofluorescent microscopical visualization of trails left by gliding Cryptosporidium parvum sporozoites. J. Parasitol.77:315–317 [PubMed] [Google Scholar]

176. Bhat N, Joe A, PereiraPerrin M, Ward HD.2007. Cryptosporidium p30, a galactose/N-acetylgalactosamine-specific lectin, mediates infection in vitro. J. Biol. Chem.282:34877–34887 [PubMed] [Google Scholar]

177. Spano F, Putignani L, Naitza S, Puri C, Wright S, Crisanti A.1998. Molecular cloning and expression analysis of a Cryptosporidium parvum gene encoding a new member of the thrombospondin family. Mol. Biochem. Parasitol.92:147–162 [PubMed] [Google Scholar]

178. Nesterenko MV, Woods K, Upton SJ.1999. Receptor/ligand interactions between Cryptosporidium parvum and the surface of the host cell. Biochim. Biophys. Acta1454:165–173 [PubMed] [Google Scholar]

179. Bjorneby JM, Riggs MW, Perryman LE.1990. Cryptosporidium parvum merozoites share neutralization-sensitive epitopes with sporozoites. J. Immunol.145:298–304 [PubMed] [Google Scholar]

180. Riggs MW, McGuire TC, Mason PH, Perryman LE.1989. Neutralization-sensitive epitopes are exposed on the surface of infectious Cryptosporidium parvum sporozoites. J. Immunol.143:1340–1345 [PubMed] [Google Scholar]

181. Tosini F, Agnoli A, Mele R, Gomez Morales MA, Pozio E.2004. A new modular protein of Cryptosporidium parvum, with ricin B and LCCL domains, expressed in the sporozoite invasive stage. Mol. Biochem. Parasitol.134:137–147 [PubMed] [Google Scholar]

182. Pollok RC, McDonald V, Kelly P, Farthing MJ.2003. The role of Cryptosporidium parvum-derived phospholipase in intestinal epithelial cell invasion. Parasitol. Res.90:181–186 [PubMed] [Google Scholar]

183. Steele MI, Kuhls TL, Nida K, Meka CS, Halabi IM, Mosier DA, Elliott W, Crawford DL, Greenfield RA.1995. A Cryptosporidium parvum genomic region encoding hemolytic activity. Infect. Immun.63:3840–3845 [PMC free article] [PubMed] [Google Scholar]

184. Perkins ME, Riojas YA, Wu TW, Le Blancq SM.1999. CpABC, a Cryptosporidium parvum ATP-binding cassette protein at the host-parasite boundary in intracellular stages. Proc. Natl. Acad. Sci. U. S. A.96:5734–5739 [PMC free article] [PubMed] [Google Scholar]

185. LaGier MJ, Zhu G, Keithly JS.2001. Characterization of a heavy metal ATPase from the apicomplexan Cryptosporidium parvum. Gene266:25–34 [PubMed] [Google Scholar]

186. LaGier MJ, Keithly JS, Zhu G.2002. Characterisation of a novel transporter from Cryptosporidium parvum. Int. J. Parasitol.32:877–887 [PubMed] [Google Scholar]

187. Khramtsov NV, Tilley M, Blunt DS, Montelone BA, Upton SJ.1995. Cloning and analysis of a Cryptosporidium parvum gene encoding a protein with hom*ology to cytoplasmic form Hsp70. J. Eukaryot. Microbiol.42:416–422 [PubMed] [Google Scholar]

188. Zhu G, LaGier MJ, Stejskal F, Millership JJ, Cai X, Keithly JS.2002. Cryptosporidium parvum: the first protist known to encode a putative polyketide synthase. Gene298:79–89 [PubMed] [Google Scholar]

189. Nesterenko MV, Tilley M, Upton SJ.1995. A metallo-dependent cysteine proteinase of Cryptosporidium parvum associated with the surface of sporozoites. Microbios83:77–88 [PubMed] [Google Scholar]

190. Camero L, Shulaw WP, Xiao L.2003. Characterization of a Cryptosporidium parvum gene encoding a protein with hom*ology to long chain fatty acid synthetase. J. Eukaryot. Microbiol.50(Suppl):534–538 [PubMed] [Google Scholar]

191. Wanyiri JW, Techasintana P, O'Connor RM, Blackman MJ, Kim K, Ward HD.2009. Role of CpSUB1, a subtilisin-like protease, in Cryptosporidium parvum infection in vitro. Eukaryot. Cell8:470–477 [PMC free article] [PubMed] [Google Scholar]

192. Putignani L, Possenti A, Cherchi S, Pozio E, Crisanti A, Spano F.2008. The thrombospondin-related protein CpMIC1 (CpTSP8) belongs to the repertoire of micronemal proteins of Cryptosporidium parvum. Mol. Biochem. Parasitol.157:98–101 [PubMed] [Google Scholar]

193. O'Connor RM, Burns PB, Ha-Ngoc T, Scarpato K, Khan W, Kang G, Ward H.2009. Polymorphic mucin antigens CpMuc4 and CpMuc5 are integral to Cryptosporidium parvum infection in vitro. Eukaryot. Cell8:461–469 [PMC free article] [PubMed] [Google Scholar]

194. Langer RC, Riggs MW.1999. Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells. Infect. Immun.67:5282–5291 [PMC free article] [PubMed] [Google Scholar]

195. Schaefer DA, Auerbach-Dixon BA, Riggs MW.2000. Characterization and formulation of multiple epitope-specific neutralizing monoclonal antibodies for passive immunization against cryptosporidiosis. Infect. Immun.68:2608–2616 [PMC free article] [PubMed] [Google Scholar]

196. Langer RC, Schaefer DA, Riggs MW.2001. Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL. Infect. Immun.69:1661–1670 [PMC free article] [PubMed] [Google Scholar]

197. Barnes DA, Bonnin A, Huang JX, Gousset L, Wu J, Gut J, Doyle P, Dubremetz JF, Ward H, Petersen C.1998. A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion. Mol. Biochem. Parasitol.96:93–110 [PubMed] [Google Scholar]

198. Bonnin A, Ojcius DM, Souque P, Barnes DA, Doyle PS, Gut J, Nelson RG, Petersen C, Dubremetz JF.2001. Characterization of a monoclonal antibody reacting with antigen-4 domain of gp900 in Cryptosporidium parvum invasive stages. Parasitol. Res.87:589–592 [PubMed] [Google Scholar]

199. Petersen C, Barnes DA, Gousset L.1997. Cryptosporidium parvum GP900, a unique invasion protein. J. Eukaryot. Microbiol.44:89S–90Sdoi:10.1111/j.1550-7408.1997.tb05802.x [PubMed] [Google Scholar]

200. Sulaiman I, Lal AA, Xiao L.2001. A population genetic study of the Cryptosporidium parvum human genotype parasites. J. Eukaryot. Microbiol.2001(Suppl):24S–27Sdoi:10.1111/j.1550-7408.2001.tb00441.x [PubMed] [Google Scholar]

201. Alves M, Xiao L, Sulaiman I, Lal AA, Matos O, Antunes F.2003. Subgenotype analysis of Cryptosporidium isolates from humans, cattle, and zoo ruminants in Portugal. J. Clin. Microbiol.41:2744–2747 [PMC free article] [PubMed] [Google Scholar]

202. Feltus D, Giddings CW, Schneck BL, Monson T, Warshauer D, McEvoy JM.2006. Evidence supporting zoonotic transmission of Cryptosporidium spp. in Wisconsin. J. Clin. Microbiol.44:4303–4308 [PMC free article] [PubMed] [Google Scholar]

203. Mallon M, MacLeod A, Wastling JM, Smith H, Tait A.2003. Multilocus genotyping of Cryptosporidium parvum type 2: population genetics and sub-structuring. Infect. Genet. Evol.3:207–218 [PubMed] [Google Scholar]

204. Peng MM, Matos O, Gatei W, Das P, Stantic-Pavlinic M, Bern C, Sulaiman IM, Glaberman S, Lal AA, Xiao L.2001. A comparison of Cryptosporidium subgenotypes from several geographic regions. J. Eukaryot. Microbiol.2001(Suppl):28S–31Sdoi:10.1111/j.1550-7408.2001.tb00442.x [PubMed] [Google Scholar]

205. Peng MM, Wilson ML, Holland RE, Meshnick SR, Lal AA, Xiao L.2003. Genetic diversity of Cryptosporidium spp. in cattle in Michigan: implications for understanding the transmission dynamics. Parasitol. Res.90:175–180 [PubMed] [Google Scholar]

206. Sulaiman I, Hira PR, Zhou L, Al-Ali FM, Al-Shelahi FA, Shweiki HM, Iqbal J, Khalid N, Xiao L.2005. Unique endemicity of cryptosporidiosis in children in Kuwait. J. Clin. Microbiol.43:2805–2809 [PMC free article] [PubMed] [Google Scholar]

207. Thompson H, Dooley JS, Kenny J, McCoy M, Lowery CJ, Moore JE, Xiao L.2007. Genotypes and subtypes of Cryptosporidium spp. in neonatal calves in Northern Ireland. Parasitol. Res.100:619–624 [PMC free article] [PubMed] [Google Scholar]

208. Trotz-Williams L, Martin DS, Gatei W, Cama V, Peregrine AS, Martin SW, Nydam DV, Jamieson F, Xiao L.2006. Genotype and subtype analyses of Cryptosporidium isolates from dairy calves and humans in Ontario. Parasitol. Res.99:346–352 [PubMed] [Google Scholar]

209. Widmer G.2009. Meta-analysis of a polymorphic surface glycoprotein of the parasitic protozoa Cryptosporidium parvum and Cryptosporidium hominis. Epidemiol. Infect.137:1800–1808 [PMC free article] [PubMed] [Google Scholar]

210. Xiao L, Ryan UM.2004. Cryptosporidiosis: an update in molecular epidemiology. Curr. Opin. Infect. Dis.17:483–490 [PubMed] [Google Scholar]

211. Feng Y, Wang L, Duan L, Gomez-Puerta LA, Zhang L, Zhao X, Hu J, Zhang N, Xiao L.2012. Extended outbreak of cryptosporidiosis in a pediatric hospital, China. Emerg. Infect. Dis.18:312–314 [PMC free article] [PubMed] [Google Scholar]

212. O'Connor R, Wanyiri JW, Wojczyk BS, Kim K, Ward H.2007. Stable expression of Cryptosporidium parvum glycoprotein gp40/15 in Toxoplasma gondii. Mol. Biochem. Parasitol.152:149–158 [PMC free article] [PubMed] [Google Scholar]

213. Power ML, Cheung-Kwok-Sang C, Slade M, Williamson S.2009. Cryptosporidium fayeri: diversity within the GP60 locus of isolates from different marsupial hosts. Exp. Parasitol.121:219–223 [PubMed] [Google Scholar]

214. Priest J, Kwon JP, Arrowood MJ, Lammie PJ.2000. Cloning of the immunodominant 17-kDa antigen from Cryptosporidium parvum. Mol. Biochem. Parasitol.106:261–271 [PubMed] [Google Scholar]

215. Sestak K, Ward LA, Sheoran A, Feng X, Akiyoshi DE, Ward HD, Tzipori S.2002. Variability among Cryptosporidium parvum genotype 1 and 2 immunodominant surface glycoproteins. Parasite Immunol.24:213–219 [PubMed] [Google Scholar]

216. Priest JW, Xie LT, Arrowood MJ, Lammie PJ.2001. The immunodominant 17-kDa antigen from Cryptosporidium parvum is glycosylphosphatidylinositol-anchored. Mol. Biochem. Parasitol.113:117–126 [PubMed] [Google Scholar]

217. Gut J, Nelson RG.1994. Cryptosporidium parvum sporozoites deposit trails of 11A5 antigen during gliding locomotion and shed 11A5 antigen during invasion of MDCK cells in vitro. J. Eukaryot. Microbiol.41:42S–43S [PubMed] [Google Scholar]

218. Winter G, Gooley AA, Williams KL, Slade MB.2000. Characterization of a major sporozoite surface glycoprotein of Cryptosporidum parvum. Funct. Integr. Genomics1:207–217 [PubMed] [Google Scholar]

219. O'Hara SP, Chen XM.2011. The cell biology of cryptosporidium infection. Microbes Infect.13:721–730 [PMC free article] [PubMed] [Google Scholar]

220. Mead JR, Arrowood MJ, Sterling CR.1988. Antigens of Cryptosporidium sporozoites recognized by immune sera of infected animals and humans. J. Parasitol.74:135–143 [PubMed] [Google Scholar]

221. Reperant JM, Naciri M, Iochmann S, Tilley M, Bout DT.1994. Major antigens of Cryptosporidium parvum recognised by serum antibodies from different infected animal species and man. Vet. Parasitol.55:1–13 [PubMed] [Google Scholar]

222. Riggs MW, Cama VA, Leary HL, Jr, Sterling CR.1994. Bovine antibody against Cryptosporidium parvum elicits a circ*msporozoite precipitate-like reaction and has immunotherapeutic effect against persistent cryptosporidiosis in SCID mice. Infect. Immun.62:1927–1939 [PMC free article] [PubMed] [Google Scholar]

223. Tilley M, Eggleston MT, Upton SJ.1993. Multiple oral inoculations with Cryptosporidium parvum as a means of immunization for production of monoclonal antibodies. FEMS Microbiol. Lett.113:235–240 [PubMed] [Google Scholar]

224. Soldati D, Dubremetz JF, Lebrun M.2001. Microneme proteins: structural and functional requirements to promote adhesion and invasion by the apicomplexan parasite Toxoplasma gondii. Int. J. Parasitol.31:1293–1302 [PubMed] [Google Scholar]

225. Adams RB, Guerrant RL, Zu S, Fang G, Roche JK.1994. Cryptosporidium parvum infection of intestinal epithelium: morphologic and functional studies in an in vitro model. J. Infect. Dis.169:170–177 [PubMed] [Google Scholar]

226. Que X, Reed SL.2000. Cysteine proteinases and the pathogenesis of amebiasis. Clin. Microbiol. Rev.13:196–206 [PMC free article] [PubMed] [Google Scholar]

227. Shenai BR, Sijwali PS, Singh A, Rosenthal PJ.2000. Characterization of native and recombinant falcipain-2, a principal trophozoite cysteine protease and essential hemoglobinase of Plasmodium falciparum. J. Biol. Chem.275:29000–29010 [PubMed] [Google Scholar]

228. Shin MH, Kita H, Park HY, Seoh JY.2001. Cysteine protease secreted by Paragonimus westermani attenuates effector functions of human eosinophils stimulated with immunoglobulin G. Infect. Immun.69:1599–1604 [PMC free article] [PubMed] [Google Scholar]

229. Forney JR, Yang S, Du C, Healey MC.1996. Efficacy of serine protease inhibitors against Cryptosporidium parvum infection in a bovine fallopian tube epithelial cell culture system. J. Parasitol.82:638–640 [PubMed] [Google Scholar]

230. Miller CM, Akratos C, Johnson AM, Smith NC.2000. The production of a 70 kDa heat shock protein by Toxoplasma gondii RH strain in immunocompromised mice. Int. J. Parasitol.30:1467–1473 [PubMed] [Google Scholar]

231. Woods KM, Tilley M, Iseli A, Upton SJ, Montelone BA, Khramtsov NV.1999. Sequence of the gene encoding hsp90e from Cryptosporidium parvum. DNA Seq.10:339–342 [PubMed] [Google Scholar]

232. Morgan U, Weber R, Xiao L, Sulaiman I, Thompson RC, Ndiritu W, Lal A, Moore A, Deplazes P.2000. Molecular characterization of Cryptosporidium isolates obtained from human immunodeficiency virus-infected individuals living in Switzerland, Kenya, and the United States. J. Clin. Microbiol.38:1180–1183 [PMC free article] [PubMed] [Google Scholar]

233. Sulaiman I, Morgan UM, Thompson RC, Lal AA, Xiao L.2000. Phylogenetic relationships of Cryptosporidium parasites based on the 70-kilodalton heat shock protein (HSP70) gene. Appl. Environ. Microbiol.66:2385–2391 [PMC free article] [PubMed] [Google Scholar]

234. Lyons RE, Johnson AM.1998. Gene sequence and transcription differences in 70 kDa heat shock protein correlate with murine virulence of Toxoplasma gondii. Int. J. Parasitol.28:1041–1051 [PubMed] [Google Scholar]

235. Lyons RE, Johnson AM.1995. Heat shock proteins of Toxoplasma gondii. Parasite Immunol.17:353–359 [PubMed] [Google Scholar]

236. Moxon ER, Rainey PB, Nowak MA, Lenski RE.1994. Adaptive evolution of highly mutable loci in pathogenic bacteria. Curr. Biol.4:24–33 [PubMed] [Google Scholar]

237. Deitsch KW, Moxon ER, Wellems TE.1997. Shared themes of antigenic variation and virulence in bacterial, protozoal, and fungal infections. Microbiol. Mol. Biol. Rev.61:281–293 [PMC free article] [PubMed] [Google Scholar]

238. Henderson IR, Owen P, Nataro JP.1999. Molecular switches—the ON and OFF of bacterial phase variation. Mol. Microbiol.33:919–932 [PubMed] [Google Scholar]

239. Barry JD, Ginger ML, Burton P, McCulloch R.2003. Why are parasite contingency genes often associated with telomeres?Int. J. Parasitol.33:29–45 [PubMed] [Google Scholar]

240. Yang X, Figueiredo LM, Espinal A, Okubo E, Li B.2009. RAP1 is essential for silencing telomeric variant surface glycoprotein genes in Trypanosoma brucei. Cell137:99–109 [PMC free article] [PubMed] [Google Scholar]

241. Kyes S, Horrocks P, Newbold C.2001. Antigenic variation at the infected red cell surface in malaria. Annu. Rev. Microbiol.55:673–707 [PubMed] [Google Scholar]

242. Kim D, Chiurillo MA, El-Sayed N, Jones K, Santos MR, Porcile PE, Andersson B, Myler P, da Silveira JF, Ramirez JL.2005. Telomere and subtelomere of Trypanosoma cruzi chromosomes are enriched in (pseudo)genes of retrotransposon hot spot and trans-sialidase-like gene families: the origins of T. cruzi telomeres. Gene346:153–161 [PubMed] [Google Scholar]

243. Benfield TL, Lundgren JD.1998. The Pneumocystis carinii major surface glycoprotein (MSG): its potential involvement in the pathophysiology of pneumocystosis. FEMS Immunol. Med. Microbiol.22:129–134 [PubMed] [Google Scholar]

244. Schmuckli-Maurer J, Casanova C, Schmied S, Affentranger S, Parvanova I, Kang'A S, Nene V, Katzer F, McKeever D, Muller J, Bishop R, Pain A, Dobbelaere DA.2009. Expression analysis of the Theileria parva subtelomere-encoded variable secreted protein gene family. PLoS One4:e4839doi:10.1371/journal.pone.0004839 [PMC free article] [PubMed] [Google Scholar]

245. Widmer G, Tzipori S, Fichtenbaum CJ, Griffiths JK.1998. Genotypic and phenotypic characterization of Cryptosporidium parvum isolates from people with AIDS. J. Infect. Dis.178:834–840 [PubMed] [Google Scholar]

246. Petry F, Jakobi V, Tessema TS.2010. Host immune response to Cryptosporidium parvum infection. Exp. Parasitol.126:304–309 [PubMed] [Google Scholar]

247. Flanigan T, Whalen C, Turner J, Soave R, Toerner J, Havlir D, Kotler D.1992. Cryptosporidium infection and CD4 counts. Ann. Intern. Med.116:840–842 [PubMed] [Google Scholar]

248. Schmidt W, Wahnschaffe U, Schäfer M, Zippel T, Arvand M, Meyerhans A, Riecken EO, Ullrich R.2001. Rapid increase of mucosal CD4 T cells followed by clearance of intestinal cryptosporidiosis in an AIDS patient receiving highly active antiretroviral therapy. Gastroenterology120:984–987 [PubMed] [Google Scholar]

249. Kocoshis SA, Cibull ML, Davis TE, Hinton JT, Seip M, Banwell JG.1984. Intestinal and pulmonary cryptosporidiosis in an infant with severe combined immune deficiency. J. Pediatr. Gastroenterol. Nutr.3:149–157 [PubMed] [Google Scholar]

250. Hayward AR, Levy J, Facchetti F, Notarangelo L, Ochs HD, Etzioni A, Bonnefoy JY, Cosyns M, Weinberg A.1997. Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X-linked immunodeficiency with hyper-IgM. J. Immunol.158:977–983 [PubMed] [Google Scholar]

251. Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD.1997. Clinical spectrum of X-linked hyper-IgM syndrome. J. Pediatr.131:47–54 [PubMed] [Google Scholar]

252. Wolska-Kusnierz B, Bajer A, Caccio S, Heropolitanska-Pliszka E, Bernatowska E, Socha P, van Dongen J, Bednarska M, Paziewska A, Sinski E.2007. Cryptosporidium infection in patients with primary immunodeficiencies. J. Pediatr. Gastroenterol. Nutr.45:458–464 [PubMed] [Google Scholar]

253. Anonymous1997. Primary immunodeficiency diseases. Report of a WHO scientific group. Clin. Exp. Immunol.109(Suppl 1):1–28 [PubMed] [Google Scholar]

254. Gomez Morales MA, Ausiello CM, Guarino A, Urbani F, Spagnuolo MI, Pignata C, Pozio E.1996. Severe, protracted intestinal cryptosporidiosis associated with interferon gamma deficiency: pediatric case report. Clin. Infect. Dis.22:848–850 [PubMed] [Google Scholar]

255. Clifford CP, Crook DW, Conlon CP, Fraise AP, Day DG, Peto TE.1990. Impact of waterborne outbreak of cryptosporidiosis on AIDS and renal transplant patients. Lancet335:1455–1456 [PubMed] [Google Scholar]

256. Collier AC, Miller RA, Meyers JD.1984. Cryptosporidiosis after marrow transplantation: person-to-person transmission and treatment with spiramycin. Ann. Intern. Med.101:205–206 [PubMed] [Google Scholar]

257. Gentile G, Venditti M, Micozzi A, Caprioli A, Donelli G, Tirindelli C, Meloni G, Arcese W, Martino P.1991. Cryptosporidiosis in patients with hematologic malignancies. Rev. Infect. Dis.13:842–846 [PubMed] [Google Scholar]

258. McAnulty JM, Keene WE, Leland D, Hoesly F, Hinds B, Stevens G, Fleming DW.2000. Contaminated drinking water in one town manifesting as an outbreak of cryptosporidiosis in another. Epidemiol. Infect.125:79–86 [PMC free article] [PubMed] [Google Scholar]

259. Hunter PR, Quigley C.1998. Investigation of an outbreak of cryptosporidiosis associated with treated surface water finds limits to the value of case control studies. Commun. Dis. Public Health1:234–238 [PubMed] [Google Scholar]

260. Chappell CL, Okhuysen PC, Sterling CR, Wang C, Jakubowski W, Dupont HL.1999. Infectivity of Cryptosporidium parvum in healthy adults with pre-existing anti-C. parvum serum immunoglobulin G. Am. J. Trop. Med. Hyg.60:157–164 [PubMed] [Google Scholar]

261. Okhuysen PC, Chappell CL, Sterling CR, Jakubowski W, DuPont HL.1998. Susceptibility and serologic response of healthy adults to reinfection with Cryptosporidium parvum. Infect. Immun.66:441–443 [PMC free article] [PubMed] [Google Scholar]

262. Craun GF, Hubbs SA, Frost F, Calderon RL, Via SH.1998. Waterborne outbreaks of cryptosporidiosis. J. Am. Water Works Assoc.90:81–91 [Google Scholar]

263. Swift L, Hunter PR.2004. What do negative associations between potential risk factors and illness in analytical epidemiological studies of infectious disease really mean?Eur. J. Epidemiol.19:219–223 [PubMed] [Google Scholar]

264. Hunter PR, de Sylor MA, Risebro HL, Nichols GL, Kay D, Hartemann P.2011. Quantitative microbial risk assessment of cryptosporidiosis and giardiasis from very small private water supplies. Risk Anal.31:228–236 [PubMed] [Google Scholar]

265. Hunter PR, Zmirou-Navier D, Hartemann P.2009. Estimating the impact on health of poor reliability of drinking water interventions in developing countries. Sci. Total Environ.407:2621–2624 [PubMed] [Google Scholar]

266. Coutinho BP, Oria RB, Vieira CM, Sevilleja JE, Warren CA, Maciel JG, Thompson MR, Pinkerton RC, Lima AA, Guerrant RL.2008. Cryptosporidium infection causes undernutrition and, conversely, weanling undernutrition intensifies infection. J. Parasitol.94:1225–1232 [PMC free article] [PubMed] [Google Scholar]

267. Mor SM, Tzipori S.2008. Cryptosporidiosis in children in sub-Saharan Africa: a lingering challenge. Clin. Infect. Dis.47:915–921 [PMC free article] [PubMed] [Google Scholar]

268. Hunter P, Hughes S, Woodhouse S, Syed Q, Verlander NQ, Chalmers RM, Morgan K, Nichols G, Beeching N, Osborn K.2004. Sporadic cryptosporidiosis case-control study with genotyping. Emerg. Infect. Dis.10:1241–1249 [PMC free article] [PubMed] [Google Scholar]

269. Elwin K, Hadfield SJ, Robinson G, Chalmers RM.2012. The epidemiology of sporadic human infections with unusual cryptosporidia detected during routine typing in England and Wales, 2000-2008. Epidemiol. Infect.140:673–683 [PubMed] [Google Scholar]

270. Van Valen L.1973. A new evolutionary law. Evol. Theory1:1–30 [Google Scholar]

271. Venditti C, Meade A, Pagel M.2010. Phylogenies reveal new interpretation of speciation and the Red Queen. Nature463:349–352 [PubMed] [Google Scholar]

272. Lively CM, Dybdahl MF.2000. Parasite adaptation to locally common host genotypes. Nature405:679–681 [PubMed] [Google Scholar]

273. Engelstadter J, Bonhoeffer S.2009. Red Queen dynamics with non-standard fitness interactions. PLoS Comput. Biol.5:e1000469doi:10.1371/journal.pcbi.1000469 [PMC free article] [PubMed] [Google Scholar]

274. Ebert D.1994. Virulence and local adaptation of a horizontally transmitted parasite. Science265:1084–1086 [PubMed] [Google Scholar]

275. Anderson RM, May RM.1982. Coevolution of hosts and parasites. Parasitology85(Part 2):411–426 [PubMed] [Google Scholar]

276. Brubaker RR.1985. Mechanisms of bacterial virulence. Annu. Rev. Microbiol.39:21–50 [PubMed] [Google Scholar]

277. O'Hara SP, Yu JR, Lin JJ.2004. A novel Cryptosporidium parvum antigen, CP2, preferentially associates with membranous structures. Parasitol. Res.92:317–327 [PubMed] [Google Scholar]

Cryptosporidium Pathogenicity and Virulence (2024)

FAQs

What is the virulence factor of Cryptosporidium? ›

Putative virulence factors for Cryptosporidium have been identified as genes involved in the initial interaction processes of Cryptosporidium oocysts and sporozoites with host epithelial cells, including excystation, gliding motility, attachment, invasion, parasitophorous vacuole formation, intracellular maintenance, ...

What is the pathogenicity of Cryptosporidium? ›

Cryptosporidium parvum can be regarded as a minimally invasive mucosal pathogen, since it invades surface epithelial cells that line the intestinal tract but does not invade deeper layers of the intestinal mucosa. Nonetheless, infection can be associated with diarrhea and marked mucosal inflammation.

What is the difference between pathogenicity and virulence? ›

Pathogenicity is defined as “the quality or state or being pathogenic, the potential or ability to produce disease”, whereas virulence is defined as “the disease producing power of an organism, the degree of pathogenicity within a group or species” (Shapiro-Ilan et al., 2005).

What are virulence factors pathogenicity? ›

Virulence factors help bacteria to (1) invade the host, (2) cause disease, and (3) evade host defenses. The following are types of virulence factors: Adherence Factors: Many pathogenic bacteria colonize mucosal sites by using pili (fimbriae) to adhere to cells.

What is the pathophysiology of cryptosporidiosis? ›

Cryptosporidiosis typically presents with watery diarrhea. The mechanism by which Cryptosporidium causes diarrhea includes a combination of increased intestinal permeability, chloride secretion, and malabsorption, which are all thought to be mediated by the host response to infection.

What is the key virulence factor? ›

The flagellum is a key virulence factor in urinary tract infections because it helps the bacteria spread up the urethra. Pili are shorter filaments that aid in attachment. Greater ability to adhere to tissues improves the bacteria's infectivity. One of the more significant virulence factors of bacteria is exotoxins.

How does Cryptosporidium cause disease? ›

Cryptosporidiosis is caused by the parasite Cryptosporidium. Once inside your body, the parasite passes through your digestive tract and infects your intestines and stool. Anything contaminated with the infected stool can pass the infection on to other people.

What are the virulence factors of protozoa? ›

Protozoan Virulence

Protozoan pathogens are unicellular eukaryotic parasites that have virulence factors and pathogenic mechanisms analogous to prokaryotic and viral pathogens, including adhesins, toxins, antigenic variation, and the ability to survive inside phagocytic vesicles.

What is the immune response to Cryptosporidium? ›

Adaptive immune responses

T-cell immune responses play a critical role in resolution of cryptosporidial infection, predominantly via CD4+ cells and IFN-γ-mediated pathways. IFN-γ may play a role in T-cell memory responses.

Which of the following distinguishes virulence from pathogenicity? ›

Pathogenicity is defined by the capacity of a microbe to cause damage in a (susceptible) host. Virulence is defined as the relative capacity of a microbe to cause damage in a host.

What do you mean by virulence? ›

Virulence is a pathogen's or microorganism's ability to cause damage to a host. In most, especially in animal systems, virulence refers to the degree of damage caused by a microbe to its host. The pathogenicity of an organism—its ability to cause disease—is determined by its virulence factors.

What is the difference between a microbe's pathogenicity and its virulence factors? ›

In this review, pathogenicity is defined as the capacity of a parasite to cause damage in a host, virulence as the relative capacity of the parasite to cause damage in a host, and virulence factors as parasite components that damage the host, including essential components for viability.

How to identify virulence factors? ›

In the pregenomic era, systematic identification of virulence factors were typically done either by biochemical approaches or through genetic screens for genes expressed under in vivo conditions or essential for survival in the host (e.g. In Vivo Expression Technology (IVET) [1]; Signature-Tagged Mutagenesis (STM) [2]) ...

What is the definition of pathogenicity? ›

Pathogenicity refers to the ability of an organism to cause disease (ie, harm the host). This ability represents a genetic component of the pathogen and the overt damage done to the host is a property of the host-pathogen interactions. Commensals and opportunistic pathogens lack this inherent ability to cause disease.

What is the best definition of virulence factors? ›

Virulence factors are classically defined as those implicated in critical steps of the infectious life cycle of a given microorganism.

What are the virulence factors of Cryptococcus? ›

The ability to produce a large capsule and shed great amounts of capsular material into the body fluids makes the organism highly virulent. Other factors, such as melanin, mannitol, superoxide dismutase, protease, and phospholipase production, may enhance the pathogenicity of C.

What are the virulence factors of proteins? ›

Virulence is described as an ability of an organism to infect the host and cause a disease. Virulence factors are the molecules that assist the bacterium colonize the host at the cellular level. These factors are either secretory, membrane associated or cytosolic in nature.

What is virulence factor? ›

Virulence factors are bacteria-associated molecules that are required for a bacterium to cause disease while infecting eukaryotic hosts such as humans. A surprisingly large number of virulence factors are encoded by prophage infecting bacterial pathogens, such as cholera toxin, Shiga toxin, and diphtheria toxin.

Which of the following is a virulence factor? ›

These factors include adhesins, invasins, and antiphagocytic factors. Bacterial flagella that give motility are included in these virulence factors. The factors, including toxins, hemolysins and proteases, bring damage to the host.

Top Articles
How a simple hobby can positively impact your career progression and well-being. 
How can you evaluate the sensitivity of a DCF analysis?
Katie Nickolaou Leaving
Access-A-Ride – ACCESS NYC
The Definitive Great Buildings Guide - Forge Of Empires Tips
Immobiliare di Felice| Appartamento | Appartamento in vendita Porto San
Sprague Brook Park Camping Reservations
Decaying Brackenhide Blanket
Wmlink/Sspr
Jcpenney At Home Associate Kiosk
Raid Guides - Hardstuck
Caroline Cps.powerschool.com
Turning the System On or Off
Koop hier ‘verloren pakketten’, een nieuwe Italiaanse zaak en dit wil je ook even weten - indebuurt Utrecht
Craigslist Pets Longview Tx
Healing Guide Dragonflight 10.2.7 Wow Warring Dueling Guide
U/Apprenhensive_You8924
State HOF Adds 25 More Players
Wausau Obits Legacy
Vigoro Mulch Safe For Dogs
Yard Goats Score
Phoebus uses last-second touchdown to stun Salem for Class 4 football title
Jenna Ortega’s Height, Age, Net Worth & Biography
Talkstreamlive
Shadbase Get Out Of Jail
Craigs List Jonesboro Ar
Telegram Voyeur
Violent Night Showtimes Near Johnstown Movieplex
Doctors of Optometry - Westchester Mall | Trusted Eye Doctors in White Plains, NY
What is Software Defined Networking (SDN)? - GeeksforGeeks
Desales Field Hockey Schedule
Missing 2023 Showtimes Near Grand Theatres - Bismarck
Red Sox Starting Pitcher Tonight
How to Use Craigslist (with Pictures) - wikiHow
6143 N Fresno St
Diana Lolalytics
Goodwill Thrift Store & Donation Center Marietta Photos
What Time Is First Light Tomorrow Morning
Carespot Ocoee Photos
Duff Tuff
Mid America Clinical Labs Appointments
Quaally.shop
Dyi Urban Dictionary
Nope 123Movies Full
Rick And Morty Soap2Day
Richard Mccroskey Crime Scene Photos
Jimmy John's Near Me Open
Msatlantathickdream
ESPN's New Standalone Streaming Service Will Be Available Through Disney+ In 2025
Naughty Natt Farting
Noaa Duluth Mn
Latest Posts
Article information

Author: Dean Jakubowski Ret

Last Updated:

Views: 6233

Rating: 5 / 5 (70 voted)

Reviews: 93% of readers found this page helpful

Author information

Name: Dean Jakubowski Ret

Birthday: 1996-05-10

Address: Apt. 425 4346 Santiago Islands, Shariside, AK 38830-1874

Phone: +96313309894162

Job: Legacy Sales Designer

Hobby: Baseball, Wood carving, Candle making, Jigsaw puzzles, Lacemaking, Parkour, Drawing

Introduction: My name is Dean Jakubowski Ret, I am a enthusiastic, friendly, homely, handsome, zealous, brainy, elegant person who loves writing and wants to share my knowledge and understanding with you.